Silhouette

Mahmoud A Elsohly

Elsohly Laboratories, Inc.

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
Orally Active Formulations of DHA Dimers for the Treatment of Infectious Diseases
Elsohly Laboratories, Inc.
Principal Investigator
HHS 1 $206K 08/02/13 07/31/14
Development of Tetrahydrocannabinol Prodrugs for Topical Treatment of Glaucoma
Elsohly Laboratories, Inc.
Principal Investigator
HHS 1 $167K 03/01/11 02/28/13
Compositions for Prevention/Prophylactic Treatment of Poison Ivy Dermatitis
Elsohly Laboratories, Inc.
Principal Investigator
HHS 2 $367K 09/01/10 08/31/12
Compositions for Prevention/Prophylactic Treatment of Poison Ivy Dermatitis
Elsohly Laboratories, Inc.
Principal Investigator
HHS 2 $372K 09/07/09 08/31/10
Transmucosal Intra-Oral Drug Delivery System for THC
Elsohly Laboratories, Inc.
Principal Investigator
HHS 2 $214K 06/01/09 05/31/12
Transmucosal Intra-Oral Drug Delivery System for THC
Elsohly Laboratories, Inc.
Principal Investigator
HHS 2 $399K 06/01/09 05/31/12
Transmucosal Intra-Oral Drug Delivery System for THC
Elsohly Laboratories, Inc.
Principal Investigator
HHS 2 $345K 06/01/08 05/31/09
Compositions for Prevention/Prophylactic Treatment of Poison Ivy Dermatitis
Elsohly Laboratories, Inc.
Principal Investigator
HHS 1 $100K 08/15/06 07/31/07
Transmucosal Intra-Oral Drug Delivery System for THC
Elsohly Laboratories, Inc.
Principal Investigator
HHS 1 $100K 09/01/03 06/30/04
Preclinical Develop. of a New Drug for Pcp and Malaria
Elsohly Laboratories, Inc.
Principal Investigator
HHS 2 $68.5K 09/01/01 12/31/02
Development of a New Drug for P. Carinii and Malaria
Elsohly Laboratories, Inc.
Principal Investigator
HHS 2 $276K 09/15/00 08/31/01
Development of a New Formulation for Long-term Studies
Elsohly Laboratories, Inc.
Principal Investigator
HHS 2 $0.0 09/01/89 05/31/90
Development of a New Formulation for Long-term Studies
Elsohly Laboratories, Inc.
Principal Investigator
HHS 2 $0.0 09/30/88 08/31/89
Development of a Cannabis Fingerprint
Elsohly Laboratories, Inc.
Principal Investigator
HHS 1 $0.0 09/30/87 03/31/88
Dev of New Formulation for Studies of Delta 9-thc
Elsohly Laboratories, Inc.
Principal Investigator
HHS 1 $0.0 09/30/86 03/31/87